No Data
Nanwei Co., Ltd. 2024 annual results pre-loss announcement
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Nanyue Co., Ltd. (603880.SH): Xu Dong has cumulatively reduced his shareholding by 0.94%.
On December 12, Glonghui reported that Nanwei Co., Ltd. (603880.SH) announced that on August 22, 2024, the company will disclose the "Shareholding Reduction Plan Announcement for Shareholders Holding More Than 5% of Nanwei Co., Ltd.": Within 90 days after 15 trading days from the date of this announcement, Mr. Xu Dong plans to reduce his shareholding through centralized bidding, with the number of shares not exceeding 2,890,420, which is no more than 1% of the total shares of the company. Within 90 days after 15 trading days from the date of this announcement, Mr. Xu Dong plans to reduce his shareholding through block trading, with the number of shares not exceeding 5,780,840, which is no more than 2% of the total shares of the company.
Nanwei Co., Ltd.: Nanwei Co., Ltd. report for the third quarter of 2024
Nanwei Co., Ltd. 2024 Third Quarter Report
Express News | Jiangsu Nanfang Medical Says Controlling Shareholder, Chief Financial Officer Probed by Chinese Securities Regulator for Suspected Insider Trading
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
